Literature DB >> 8418052

Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388.

S M Kulich1, D W Frank, J T Barbieri.   

Abstract

Exoenzyme S was purified > 1,500-fold from the culture supernatant fluid of Pseudomonas aeruginosa 388 at high yield without utilization of solvents or detergents. Two proteins, with apparent molecular sizes of 53 and 49 kDa, cofractionated with exoenzyme S activity. Rabbit anti-49-kDa-protein immunoglobulin G was prepared by using sodium dodecyl sulfate-polyacrylamide gel electrophoresis-purified 49-kDa protein as immunogen. Anti-49-kDa-protein IgG inhibited the ADP-ribosyltransferase activity of purified exoenzyme S in a dose-dependent manner, which indicated a role for the 49-kDa protein in the ADP-ribosylation reaction. Analysis by ultrafiltration showed that exoenzyme S activity and the 53- and 49-kDa proteins cofractionated and that exoenzyme S was apparently > 300 kDa in size. Urea (8 M) and 1.0% Triton X-100 reversibly decreased the apparent molecular sizes of exoenzyme S activity and the 53- and 49-kDa proteins to between 30 and 100 kDa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418052      PMCID: PMC302720          DOI: 10.1128/iai.61.1.307-313.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Several GTP-binding proteins, including p21c-H-ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; R T Wyatt; B H Iglewski; D M Gill
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

2.  Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin.

Authors:  J Coburn; S T Dillon; B H Iglewski; D M Gill
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  The protein cofactor necessary for ADP-ribosylation of Gs by cholera toxin is itself a GTP binding protein.

Authors:  R A Kahn; A G Gilman
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

4.  ADP-ribosylation by cholera toxin: functional analysis of a cellular system that stimulates the enzymic activity of cholera toxin fragment A1.

Authors:  D M Gill; J Coburn
Journal:  Biochemistry       Date:  1987-10-06       Impact factor: 3.162

5.  Proteins transferred to nitrocellulose for use as immunogens.

Authors:  K A Knudsen
Journal:  Anal Biochem       Date:  1985-06       Impact factor: 3.365

6.  Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections.

Authors:  T I Nicas; D W Frank; P Stenzel; J D Lile; B H Iglewski
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

7.  Expression and secretion of the S-1 subunit and C180 peptide of pertussis toxin in Escherichia coli.

Authors:  J T Barbieri; B K Moloney; L M Mende-Mueller
Journal:  J Bacteriol       Date:  1989-08       Impact factor: 3.490

8.  Alteration of pulmonary structure by Pseudomonas aeruginosa exoenzyme S.

Authors:  D E Woods; W S Hwang; M S Shahrabadi; J U Que
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

9.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

10.  Purification of Pseudomonas aeruginosa exoenzyme S.

Authors:  D E Woods; J U Que
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.609

View more
  23 in total

1.  Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein.

Authors:  R Krall; G Schmidt; K Aktories; J T Barbieri
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Characterization of an ExoS Type III translocation-resistant cell line.

Authors:  Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Functional analysis of exsC and exsB in regulation of exoenzyme S production by Pseudomonas aeruginosa.

Authors:  J Goranson; A K Hovey; D W Frank
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

4.  A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells.

Authors:  Yue Zhang; Joseph T Barbieri
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa.

Authors:  S Liu; T L Yahr; D W Frank; J T Barbieri
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

6.  Adherence to lipids and intestinal mucin by a recently recognized human pathogen, Campylobacter upsaliensis.

Authors:  F A Sylvester; D Philpott; B Gold; A Lastovica; J F Forstner
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

7.  Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU.

Authors:  V Finck-Barbançon; D W Frank
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

8.  In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Authors:  Stephanie L Rolsma; Dara W Frank
Journal:  Methods Mol Biol       Date:  2014

9.  Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.

Authors:  S M Kulich; D W Frank; J T Barbieri
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus.

Authors:  J Moss; M E Ehrmantraut; B D Banwart; D W Frank; J T Barbieri
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.